HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jarod Finlay Selected Research

motexafin lutetium (Lutrin)

8/2008Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.
1/2006Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jarod Finlay Research Topics

Disease

2Neoplasms (Cancer)
10/2018 - 01/2006
2Prostatic Neoplasms (Prostate Cancer)
08/2008 - 01/2006
1Carcinoma (Carcinomatosis)
03/2011
1Mucositis
12/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2010

Drug/Important Bio-Agent (IBA)

41-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2011 - 01/2006
2motexafin lutetium (Lutrin)IBA
08/2008 - 01/2006
1Prostate-Specific Antigen (Semenogelase)IBA
08/2008
1Oxygen (Dioxygen)IBA
01/2006
1Photosensitizing Agents (Photosensitizers)IBA
01/2006
1Pharmaceutical PreparationsIBA
01/2006

Therapy/Procedure

3Radiotherapy
10/2018 - 01/2006
3Photochemotherapy (Photodynamic Therapy)
03/2011 - 01/2006
1Aftercare (After-Treatment)
01/2006
1Lasers (Laser)
01/2006